1. Smith AP, Brockman P, Flynn R, Maben A, Thomas M. (1993, April 27). Investigation of the effects of coffee on alertness and performance during the day and night. Retrieved from

2. Hindmarch, I, Rigney, U, Stanley, N. et al. (2000). Investigation of the effects of coffee on alertness and performance during the day and night. Retrieved from

3. A L McCall,W R Millington, R J Wurtman. (1982, December 13). Blood-brain barrier transport of caffeine: Dose-related restriction of adenine transport. Retrieved from

4. Bertil B. Fredholm. (February 1995). Adenosine, Adenosine Receptors and the Actions of Caffeine. Retrieved from

5. Nehlig A, Daval JL, Debry G. (1992 May-Aug). Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Retrieved from

6. C H S Ruxton. (2008 February 13). The impact of caffeine on mood, cognitive function, performance and hydration: a review of benefits and risks. Retrieved from

7. Brice, C F & Smith, A P. (2002, November). Psychopharmacology. Retrieved from

8. Lieberman, H.R., Wurtman, R.J., Emde, G.G. et al. (1987, July). Psychopharmacology. Retrieved from

9. A G. Dulloo, C A Geissler., T Horton, A Collins, D S Miller. (1989, January 01). Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Retrieved from

10. Koot P, Deurenberg P. (1995). Comparison of Changes in Energy Expenditure and Body Temperatures after Caffeine Consumption. Retrieved from

11. Acheson KJ1, Gremaud G, Meirim I, Montigon F, Krebs Y, Fay LB, Gay LJ, Schneiter P, Schindler C, Tappy L. (2004, January 01). Metabolic effects of caffeine in humans: lipid oxidation or futile cycling?. Retrieved from

12. L-K Han, T Takaku, J Li, Y Kimura & H Okuda. (1995, January 15). Anti-obesity action of oolong tea. Retrieved from

13. Kim, TW., Shin, YO., Lee, JB. et al. (2005, June 15). Food Sci Biotechnol. Retrieved from

14. Anderson DE, Hickey MS. (1994, April). Effects of caffeine on the metabolic and catecholamine responses to exercise in 5 and 28 degrees C. Retrieved from

15. Keijzers GB, De Galan BE, Tack CJ, Smits P. (2002, February). Caffeine can decrease insulin sensitivity in humans. Retrieved from

16. Patwardhan RV, Desmond PV, Johnson RF, Dunn GD, Robertson DH, Hoyumpa AM Jr, Schenker S. (1980, September). Effects of caffeine on plasma free fatty acids, urinary catecholamines, and drug binding. Retrieved from

17. S Bellet, A Kershbaum, E. Michael Finck. (2004, April 10). Response of free fatty acids to coffee and caffeine. Retrieved from

18. Doherty M, Smith PM. (2004, December). Effects of caffeine ingestion on exercise testing: a meta-analysis. Retrieved from

19. M. Doherty,  P. M. Smith. (2005, March 18). Effects of caffeine ingestion on rating of perceived exertion during and after exercise: a meta‐analysis. Retrieved from

20. The Self NutritionData (N.A). Coffee, brewed from grounds, prepared with tap water. Retrieved from

21. S. van DierenC. S. P. M. UiterwaalY. T. van der SchouwD. L. van der AJ. M. A. BoerA. SpijkermanD. E. GrobbeeJ. W. J. Beulens. (2019, December 01). Diabetologia. Retrieved from

22. Odegaard AO, Pereira MA, Koh WP, Arakawa K, Lee HP, Yu MC. (2008, October). Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Retrieved from

23. Van Dam RM1, Hu FB. (2005, July 06). Coffee consumption and risk of type 2 diabetes: a systematic review. Retrieved from

24. Rob M van Dam MSc, Edith JM Feskens PhD. (2002, November 09). Coffee consumption and risk of type 2 diabetes mellitus. Retrieved from

25. Y.Zhang, E.T.Lee, L.D.Cowan, R.R.Fabsitz, B.V.Howard. (2005, June). Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: The Strong Heart Study. Retrieved from

26. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M. (2009, December 14). Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Retrieved from

27. L. Maia,  A. De Mendonça. (2002, July 03). Does caffeine intake protect from Alzheimer's disease?. Retrieved from

28. Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N. (2010, April 14). Caffeine intake and dementia: systematic review and meta-analysis. Retrieved from

29. Miguel A. Hernán MD, DrPH, Bahi Takkouche MD, PhD, Francisco Caamaño‐Isorna PharmD,  Juan J. Gestal‐Otero MD, PhD. (2002, May 29). A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Retrieved from

30. Gang Hu MD, PhD, Siamak Bidel MD, Pekka Jousilahti MD, PhD, Riitta Antikainen MD, PhD, Jaakko Tuomilehto MD, PhD. (2007, August 21). Coffee and tea consumption and the risk of Parkinson's disease. Retrieved from

31. G. Webster Ross, MD; Robert D. Abbott, PhD; Helen Petrovitch, MD; et al. (2000, May 24/31). Association of coffee and caffeine intake with the risk of Parkinson disease. Retrieved from

32. Patwardhan RV, Desmond PV, Johnson RF, Dunn GD, Robertson DH, Hoyumpa AM Jr, Schenker S. (1980, September). Effects of caffeine on plasma free fatty acids, urinary catecholamines, and drug binding. Retrieved from

33. Ascherio A, Weisskopf MG, O'Reilly EJ, McCullough ML, Calle EE, Rodriguez C, Thun MJ. (2004, November 15). Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Retrieved from

34. Klatsky AL, Morton C, Udaltsova N, Friedman GD. (2006, June 12). Coffee, cirrhosis, and transaminase enzymes. Retrieved from

35. Gallus S, Tavani A, Negri E, La Vecchia C. (2002, April 15). Does Coffee Protect Against Liver Cirrhosis?. Retrieved from

36. Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A; Collaborative SIDECIR Group. (2001, October). Coffee, caffeine, and the risk of liver cirrhosis. Retrieved from

37. Lucas M, Mirzaei F, Pan A, Okereke OI, Willett WC, O'Reilly ÉJ, Koenen K, Ascherio A. (2011, September 26). Coffee, caffeine, and risk of depression among women. Retrieved from

38. Kawachi I, Willett WC, Colditz GA, Stampfer MJ, Speizer FE. (1996, March). A prospective study of coffee drinking and suicide in women. Retrieved from

39. World Health Organization. (2018, September 12). Cancer. Retrieved from

40. Susanna C. Larsson, Alicja Wolk. (2007, May). Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis. Retrieved from

41. Taichi Shimazu, Yoshitaka Tsubono, Shinichi Kuriyama, Kaori Ohmori, Yayoi Koizumi, Yoshikazu Nishino, Daisuke Shibuya, Ichiro Tsuji. (2005, March 08). Coffee consumption and the risk of primary liver cancer: Pooled analysis of two prospective studies in Japan Retrieved from

42. Sinha R1, Cross AJ, Daniel CR, Graubard BI, Wu JW, Hollenbeck AR, Gunter MJ, Park Y, Freedman ND. (2012, June 13). Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Retrieved from


Disclaimer: BARISTA UNO™ Pte. Ltd. (“Barista Uno”) is neither licensed or regulated by the Monetary Authority of Singapore (“MAS”). The information contained herein is solely for information purposes only, must be read in its entirety, is strictly confidential, and is supplied for the exclusive attention of the recipient. The recipient undertakes to take all reasonably necessary steps to ensure that under no circumstances should it be copied or distributed to any person other than the recipient’s accounting, investment, legal, or tax advisers.


Notwithstanding anything to the contrary, whether express, implied, or otherwise construed by operation of law:


(a) the information contained herein or part thereof: (i) does not constitute or form part of any offer, subscription, solicitation, or invitation of any offer, anywhere in the world, to subscribe and/or purchase any securities and/or products, (ii) shall not constitute an offering document; (iii) should not be treated as any sort of offering material, (iv) shall not be relied on by the recipient in connection with any commitment or contract;  


(b) no person is authorised to give any information or make any representations not contained in this website or document, and if given or made, such information or representation must not be relied upon as having been authorised by Barista Uno, its employees, representatives, agents, or any other entity giving and/or making such information and/or representation, or purporting to give and/or make such information and/or representation; and


(c) BARISTA UNO™ does not warrant that any information contained herein or any implication thereof is correct or accurate and it shall be incumbent upon the recipient to independently verify all such information and implications. You are urged to consult with your own consultants and advisors with respect to your own particular circumstances under the laws of the jurisdictions of which you are citizens, residents, domiciliaries, in which you conduct business, or otherwise apply to you.


Any decision to take any step, omit to take any step, enter into any binding agreement, enter into any scheme, etc. should be made after conducting such as your own investigations as you deem necessary, and after consulting your own accounting, legal, and tax advisors and all other relevant advisers and consultants in order to make an independent decision of the suitability and consequences of such action or inaction. You acknowledge and confirm that Barista Uno has not considered any individual recipient’s circumstances, financial situation, or personal objectives in preparing this information and that this information should not be considered as a recommendation to purchase securities, enter into any binding agreement, enter into any scheme, or to take any step or omit to take any step. You further acknowledge that the Barista Uno does not act as adviser or agent to you or to any of your clients or customers (if any).


The recipient undertakes to indemnify BARISTA UNO™ on a full indemnity basis for all damages, expenses, costs, penalties, losses, or any other amount incurred or suffered by Barista Uno reasonably arising from breach and/or intended or anticipatory breach of any of the obligations of the recipient.

Our website contains general medical information. The medical information is not advice and should not be treated as such. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.

© 2020 by BARISTA UNO Pte Ltd